{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:53:48Z","timestamp":1790045628065,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T00:00:00Z","timestamp":1610150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12020-020-02583-z","type":"journal-article","created":{"date-parts":[[2021,1,9]],"date-time":"2021-01-09T16:13:08Z","timestamp":1610208788000},"page":"823-834","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Insulin-like growth factor 2 (IGF2) expression in adrenocortical disease due to PRKAR1A mutations compared to other benign adrenal tumors"],"prefix":"10.1007","volume":"72","author":[{"given":"Kiran S.","family":"Nadella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Berthon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madson Q.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7959-9842","authenticated-orcid":false,"given":"Fabio R.","family":"Faucz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine A.","family":"Stratakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,9]]},"reference":[{"issue":"4\u20135","key":"2583_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.cytogfr.2005.04.004","volume":"16","author":"A Denley","year":"2005","unstructured":"A. Denley, L.J. Cosgrove, G.W. Booker, J.C. Wallace, B.E. Forbes, Molecular interactions of the IGF system. Cytokine Growth Factor Rev. 16(4\u20135), 421\u2013439 (2005). https:\/\/doi.org\/10.1016\/j.cytogfr.2005.04.004","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"2583_CR2","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1432-1033.1990.tb15595.x","volume":"190","author":"RE Humbel","year":"1990","unstructured":"R.E. Humbel, Insulin-like growth factors I and II. Eur. J. Biochem. 190(3), 445\u2013462 (1990). https:\/\/doi.org\/10.1111\/j.1432-1033.1990.tb15595.x","journal-title":"Eur. J. Biochem."},{"issue":"5","key":"2583_CR3","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1006\/cbir.1995.1088","volume":"19","author":"C Schmid","year":"1995","unstructured":"C. Schmid, Insulin-like growth factors. Cell Biol. Int. 19(5), 445\u2013457 (1995). https:\/\/doi.org\/10.1006\/cbir.1995.1088","journal-title":"Cell Biol. Int."},{"issue":"4","key":"2583_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1677\/jme.1.02179","volume":"38","author":"S Ciarmatori","year":"2007","unstructured":"S. Ciarmatori, D. Kiepe, A. Haarmann, U. Huegel, B. Tonshoff, Signaling mechanisms leading to regulation of proliferation and differentiation of the mesenchymal chondrogenic cell line RCJ3.1C5.18 in response to IGF-I. J. Mol. Endocrinol. 38(4), 493\u2013508 (2007). https:\/\/doi.org\/10.1677\/jme.1.02179","journal-title":"J. Mol. Endocrinol."},{"issue":"7","key":"2583_CR5","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1210\/en.2005-0324","volume":"146","author":"D Kiepe","year":"2005","unstructured":"D. Kiepe, S. Ciarmatori, A. Hoeflich, E. Wolf, B. Tonshoff, Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways. Endocrinology 146(7), 3096\u20133104 (2005). https:\/\/doi.org\/10.1210\/en.2005-0324","journal-title":"Endocrinology"},{"issue":"11","key":"2583_CR6","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1359\/jbmr.2003.18.11.2043","volume":"18","author":"M Koike","year":"2003","unstructured":"M. Koike, Y. Yamanaka, M. Inoue, H. Tanaka, R. Nishimura, Y. Seino, Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK. J. Bone Miner. Res. 18(11), 2043\u20132051 (2003). https:\/\/doi.org\/10.1359\/jbmr.2003.18.11.2043","journal-title":"J. Bone Miner. Res."},{"issue":"7","key":"2583_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/s1357-2725(98)00048-x","volume":"30","author":"SD O\u2019Dell","year":"1998","unstructured":"S.D. O\u2019Dell, I.N. Day, Insulin-like growth factor II (IGF-II). Int. J. Biochem. Cell Biol. 30(7), 767\u2013771 (1998). https:\/\/doi.org\/10.1016\/s1357-2725(98)00048-x","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"2583_CR8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1128\/mcb.10.1.28","volume":"10","author":"CI Brannan","year":"1990","unstructured":"C.I. Brannan, E.C. Dees, R.S. Ingram, S.M. Tilghman, The product of the H19 gene may function as an RNA. Mol. Cell Biol. 10(1), 28\u201336 (1990). https:\/\/doi.org\/10.1128\/mcb.10.1.28","journal-title":"Mol. Cell Biol."},{"issue":"1","key":"2583_CR9","first-page":"1","volume":"2","author":"JS Sussenbach","year":"1992","unstructured":"J.S. Sussenbach, P.H. Steenbergh, P. Holthuizen, Structure and expression of the human insulin-like growth factor genes. Growth Regul. 2(1), 1\u20139 (1992)","journal-title":"Growth Regul."},{"issue":"1","key":"2583_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ng0593-98","volume":"4","author":"N Giannoukakis","year":"1993","unstructured":"N. Giannoukakis, C. Deal, J. Paquette, C.G. Goodyer, C. Polychronakos, Parental genomic imprinting of the human IGF2 gene. Nat. Genet. 4(1), 98\u2013101 (1993). https:\/\/doi.org\/10.1038\/ng0593-98","journal-title":"Nat. Genet."},{"issue":"4","key":"2583_CR11","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/mrd.1080340405","volume":"34","author":"R Goshen","year":"1993","unstructured":"R. Goshen, J. Rachmilewitz, T. Schneider, N. de-Groot, I. Ariel, Z. Palti, A.A. Hochberg, The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development. Mol. Reprod Dev. 34(4), 374\u2013379 (1993). https:\/\/doi.org\/10.1002\/mrd.1080340405","journal-title":"Mol. Reprod Dev."},{"issue":"1","key":"2583_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/ng0593-94","volume":"4","author":"R Ohlsson","year":"1993","unstructured":"R. Ohlsson, A. Nystrom, S. Pfeifer-Ohlsson, V. Tohonen, F. Hedborg, P. Schofield, F. Flam, T.J. Ekstrom, IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome. Nat. Genet. 4(1), 94\u201397 (1993). https:\/\/doi.org\/10.1038\/ng0593-94","journal-title":"Nat. Genet."},{"issue":"6","key":"2583_CR13","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/s0168-9525(99)01752-7","volume":"15","author":"MA Frevel","year":"1999","unstructured":"M.A. Frevel, J.J. Hornberg, A.E. Reeve, A potential imprint control element: identification of a conserved 42 bp sequence upstream of H19. Trends Genet. 15(6), 216\u2013H218 (1999). https:\/\/doi.org\/10.1016\/s0168-9525(99)01752-7","journal-title":"Trends Genet"},{"issue":"17","key":"2583_CR14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1101\/gad.9.17.2079","volume":"9","author":"PA Leighton","year":"1995","unstructured":"P.A. Leighton, J.R. Saam, R.S. Ingram, C.L. Stewart, S.M. Tilghman, An enhancer deletion affects both H19 and Igf2 expression. Genes Dev. 9(17), 2079\u20132089 (1995). https:\/\/doi.org\/10.1101\/gad.9.17.2079","journal-title":"Genes Dev."},{"issue":"6785","key":"2583_CR15","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/35013100","volume":"405","author":"AC Bell","year":"2000","unstructured":"A.C. Bell, G. Felsenfeld, Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 405(6785), 482\u2013485 (2000). https:\/\/doi.org\/10.1038\/35013100","journal-title":"Nature"},{"issue":"6785","key":"2583_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/35013106","volume":"405","author":"AT Hark","year":"2000","unstructured":"A.T. Hark, C.J. Schoenherr, D.J. Katz, R.S. Ingram, J.M. Levorse, S.M. Tilghman, CTCF mediates methylation-sensitive enhancer-blocking activity at the H19\/Igf2 locus. Nature 405(6785), 486\u2013489 (2000). https:\/\/doi.org\/10.1038\/35013106","journal-title":"Nature"},{"issue":"8","key":"2583_CR17","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1210\/jcem.82.8.4170","volume":"82","author":"C Gicquel","year":"1997","unstructured":"C. Gicquel, M.L. Raffin-Sanson, V. Gaston, X. Bertagna, P.F. Plouin, M. Schlumberger, A. Louvel, J.P. Luton, Y. Le Bouc, Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors. J. Clin. Endocrinol. Metab. 82(8), 2559\u20132565 (1997). https:\/\/doi.org\/10.1210\/jcem.82.8.4170","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2583_CR18","first-page":"480","volume":"56","author":"K Hibi","year":"1996","unstructured":"K. Hibi, H. Nakamura, A. Hirai, Y. Fujikake, Y. Kasai, S. Akiyama, K. Ito, H. Takagi, Loss of H19 imprinting in esophageal cancer. Cancer Res. 56(3), 480\u2013482 (1996)","journal-title":"Cancer Res."},{"issue":"2","key":"2583_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/s0304-3835(97)00264-4","volume":"119","author":"KS Kim","year":"1997","unstructured":"K.S. Kim, Y.I. Lee, Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma. Cancer Lett. 119(2), 143\u2013148 (1997). https:\/\/doi.org\/10.1016\/s0304-3835(97)00264-4","journal-title":"Cancer Lett"},{"issue":"3","key":"2583_CR20","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/(sici)1097-0215(19980130)75:3<343::aid-ijc3>3.0.co;2-2","volume":"75","author":"H Oda","year":"1998","unstructured":"H. Oda, H. Kume, Y. Shimizu, T. Inoue, T. Ishikawa, Loss of imprinting of igf2 in renal-cell carcinomas. Int J Cancer 75(3), 343\u2013346 (1998). https:\/\/doi.org\/10.1002\/(sici)1097-0215(19980130)75:3<343::aid-ijc3>3.0.co;2-2","journal-title":"Int J Cancer"},{"issue":"6422","key":"2583_CR21","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/362749a0","volume":"362","author":"O Ogawa","year":"1993","unstructured":"O. Ogawa, M.R. Eccles, J. Szeto, L.A. McNoe, K. Yun, M.A. Maw, P.J. Smith, A.E. Reeve, Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms\u2019 tumour. Nature 362(6422), 749\u2013751 (1993). https:\/\/doi.org\/10.1038\/362749a0","journal-title":"Nature"},{"issue":"7","key":"2583_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/hmg\/3.7.1117","volume":"3","author":"PV Pedone","year":"1994","unstructured":"P.V. Pedone, R. Tirabosco, A.O. Cavazzana, P. Ungaro, G. Basso, R. Luksch, M. Carli, C.B. Bruni, R. Frunzio, A. Riccio, Mono- and bi-allelic expression of insulin-like growth factor II gene in human muscle tumors. Hum. Mol. Genet. 3(7), 1117\u20131121 (1994). https:\/\/doi.org\/10.1093\/hmg\/3.7.1117","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"2583_CR23","first-page":"1836","volume":"55","author":"S Rainier","year":"1995","unstructured":"S. Rainier, C.J. Dobry, A.P. Feinberg, Loss of imprinting in hepatoblastoma. Cancer Res. 55(9), 1836\u20131838 (1995)","journal-title":"Cancer Res."},{"issue":"9","key":"2583_CR24","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1182\/blood.V91.9.3144","volume":"91","author":"GS Randhawa","year":"1998","unstructured":"G.S. Randhawa, H. Cui, J.A. Barletta, L.Z. Strichman-Almashanu, M. Talpaz, H. Kantarjian, A.B. Deisseroth, R.C. Champlin, A.P. Feinberg, Loss of imprinting in disease progression in chronic myelogenous leukemia. Blood 91(9), 3144\u20133147 (1998)","journal-title":"Blood"},{"issue":"4","key":"2583_CR25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/ng0494-332","volume":"6","author":"H Suzuki","year":"1994","unstructured":"H. Suzuki, R. Ueda, T. Takahashi, T. Takahashi, Altered imprinting in lung cancer. Nat. Genet. 6(4), 332\u2013333 (1994). https:\/\/doi.org\/10.1038\/ng0494-332","journal-title":"Nat. Genet."},{"issue":"15","key":"2583_CR26","doi-asserted-by":"publisher","first-page":"9014","DOI":"10.1074\/jbc.271.15.9014","volume":"271","author":"TH Vu","year":"1996","unstructured":"T.H. Vu, A. Hoffman, Alterations in the promoter-specific imprinting of the insulin-like growth factor-II gene in Wilms\u2019 tumor. J. Biol. Chem. 271(15), 9014\u20139023 (1996). https:\/\/doi.org\/10.1074\/jbc.271.15.9014","journal-title":"J. Biol. Chem."},{"issue":"1","key":"2583_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/ejhg.2009.106","volume":"18","author":"R Weksberg","year":"2010","unstructured":"R. Weksberg, C. Shuman, J.B. Beckwith, Beckwith-Wiedemann syndrome. Eur. J. Hum. Genet. 18(1), 8\u201314 (2010). https:\/\/doi.org\/10.1038\/ejhg.2009.106","journal-title":"Eur. J. Hum. Genet."},{"issue":"5","key":"2583_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/hmg\/2.5.549","volume":"2","author":"R Weksberg","year":"1993","unstructured":"R. Weksberg, I. Teshima, B.R. Williams, C.R. Greenberg, S.M. Pueschel, J.E. Chernos, S.B. Fowlow, E. Hoyme, I.J. Anderson, D.A. Whiteman et al. Molecular characterization of cytogenetic alterations associated with the Beckwith-Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted. Hum. Mol. Genet. 2(5), 549\u2013556 (1993). https:\/\/doi.org\/10.1093\/hmg\/2.5.549","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"2583_CR29","first-page":"113","volume":"53","author":"Y Zhang","year":"1993","unstructured":"Y. Zhang, T. Shields, T. Crenshaw, Y. Hao, T. Moulton, B. Tycko, Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am. J. Hum. Genet. 53(1), 113\u2013124 (1993)","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"2583_CR30","doi-asserted-by":"publisher","first-page":"641","DOI":"10.2217\/fon.09.45","volume":"5","author":"KJ Bussey","year":"2009","unstructured":"K.J. Bussey, M.J. Demeure, Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment. Future Oncol. 5(5), 641\u2013655 (2009). https:\/\/doi.org\/10.2217\/fon.09.45","journal-title":"Future Oncol."},{"issue":"5","key":"2583_CR31","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1210\/jcem.83.5.4816","volume":"83","author":"N Boulle","year":"1998","unstructured":"N. Boulle, A. Logie, C. Gicquel, L. Perin, Y. Le Bouc, Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors. J. Clin. Endocrinol. Metab. 83(5), 1713\u20131720 (1998). https:\/\/doi.org\/10.1210\/jcem.83.5.4816","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2583_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1210\/jc.2007-1902","volume":"93","author":"M Nesterova","year":"2008","unstructured":"M. Nesterova, I. Bossis, F. Wen, A. Horvath, L. Matyakhina, C.A. Stratakis, An immortalized human cell line bearing a PRKAR1A-inactivating mutation: effects of overexpression of the wild-type Allele and other protein kinase A subunits. J. Clin. Endocrinol. Metab. 93(2), 565\u2013571 (2008). https:\/\/doi.org\/10.1210\/jc.2007-1902","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2583_CR33","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1677\/ERC-08-0237","volume":"16","author":"PS Soon","year":"2009","unstructured":"P.S. Soon, A.J. Gill, D.E. Benn, A. Clarkson, B.G. Robinson, K.L. McDonald, S.B. Sidhu, Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocr. Relat. Cancer 16(2), 573\u2013583 (2009). https:\/\/doi.org\/10.1677\/ERC-08-0237","journal-title":"Endocr. Relat. Cancer"},{"issue":"6-7","key":"2583_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1055\/s-2007-978914","volume":"30","author":"CA Stratakis","year":"1998","unstructured":"C.A. Stratakis, L.S. Kirschner, Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm. Metab. Res. 30(6-7), 456\u2013463 (1998). https:\/\/doi.org\/10.1055\/s-2007-978914","journal-title":"Horm. Metab. Res."},{"issue":"1","key":"2583_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1530\/EJE-09-0027","volume":"161","author":"EI Bimpaki","year":"2009","unstructured":"E.I. Bimpaki, M. Nesterova, C.A. Stratakis, Abnormalities of cAMP signaling are present in adrenocortical lesions associated with ACTH-independent Cushing syndrome despite the absence of mutations in known genes. Eur. J. Endocrinol. 161(1), 153\u2013161 (2009). https:\/\/doi.org\/10.1530\/EJE-09-0027","journal-title":"Eur. J. Endocrinol"},{"issue":"8","key":"2583_CR36","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1210\/jc.2009-0516","volume":"94","author":"HP Hsiao","year":"2009","unstructured":"H.P. Hsiao, L.S. Kirschner, I. Bourdeau, M.F. Keil, S.A. Boikos, S. Verma, A.J. Robinson-White, M. Nesterova, A. Lacroix, C.A. Stratakis, Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors. J. Clin. Endocrinol. Metab. 94(8), 2930\u20132937 (2009). https:\/\/doi.org\/10.1210\/jc.2009-0516","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2583_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/79238","volume":"26","author":"LS Kirschner","year":"2000","unstructured":"L.S. Kirschner, J.A. Carney, S.D. Pack, S.E. Taymans, C. Giatzakis, Y.S. Cho, Y.S. Cho-Chung, C.A. Stratakis, Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nat. Genet. 26(1), 89\u201392 (2000). https:\/\/doi.org\/10.1038\/79238","journal-title":"Nat. Genet"},{"issue":"20","key":"2583_CR38","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1093\/hmg\/9.20.3037","volume":"9","author":"LS Kirschner","year":"2000","unstructured":"L.S. Kirschner, F. Sandrini, J. Monbo, J.P. Lin, J.A. Carney, C.A. Stratakis, Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the carney complex. Hum. Mol. Genet. 9(20), 3037\u20133046 (2000). https:\/\/doi.org\/10.1093\/hmg\/9.20.3037","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"2583_CR39","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/ng1809","volume":"38","author":"A Horvath","year":"2006","unstructured":"A. Horvath, S. Boikos, C. Giatzakis, A. Robinson-White, L. Groussin, K.J. Griffin, E. Stein, E. Levine, G. Delimpasi, H.P. Hsiao, M. Keil, S. Heyerdahl, L. Matyakhina, R. Libe, A. Fratticci, L.S. Kirschner, K. Cramer, R.C. Gaillard, X. Bertagna, J.A. Carney, J. Bertherat, I. Bossis, C.A. Stratakis, A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia. Nat. Genet. 38(7), 794\u2013800 (2006). https:\/\/doi.org\/10.1038\/ng1809","journal-title":"Nat. Genet."},{"issue":"7","key":"2583_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1056\/NEJMc0706182","volume":"358","author":"A Horvath","year":"2008","unstructured":"A. Horvath, V. Mericq, C.A. Stratakis, Mutation in PDE8B, a cyclic AMP-specific phosphodiesterase in adrenal hyperplasia. N. Engl. J. Med. 358(7), 750\u2013752 (2008). https:\/\/doi.org\/10.1056\/NEJMc0706182","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"2583_CR41","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1158\/1078-0432.CCR-08-0106","volume":"14","author":"R Libe","year":"2008","unstructured":"R. Libe, A. Fratticci, J. Coste, F. Tissier, A. Horvath, B. Ragazzon, F. Rene-Corail, L. Groussin, X. Bertagna, M.L. Raffin-Sanson, C.A. Stratakis, J. Bertherat, Phosphodiesterase 11A (PDE11A) and genetic predisposition to adrenocortical tumors. Clin. Cancer Res. 14(12), 4016\u20134024 (2008). https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0106","journal-title":"Clin. Cancer Res."},{"issue":"22","key":"2583_CR42","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","volume":"369","author":"G Assie","year":"2013","unstructured":"G. Assie, R. Libe, S. Espiard, M. Rizk-Rabin, A. Guimier, W. Luscap, O. Barreau, L. Lefevre, M. Sibony, L. Guignat, S. Rodriguez, K. Perlemoine, F. Rene-Corail, F. Letourneur, B. Trabulsi, A. Poussier, N. Chabbert-Buffet, F. Borson-Chazot, L. Groussin, X. Bertagna, C.A. Stratakis, B. Ragazzon, J. Bertherat, ARMC5 mutations in macronodular adrenal hyperplasia with Cushing\u2019s syndrome. N. Engl. J. Med. 369(22), 2105\u20132114 (2013). https:\/\/doi.org\/10.1056\/NEJMoa1304603","journal-title":"N. Engl. J. Med."},{"key":"2583_CR43","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.mce.2016.08.018","volume":"441","author":"A Berthon","year":"2017","unstructured":"A. Berthon, F. Faucz, J. Bertherat, C.A. Stratakis, Analysis of ARMC5 expression in human tissues. Mol Cell Endocrinol. 441, 140\u2013145 (2017). https:\/\/doi.org\/10.1016\/j.mce.2016.08.018","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"2583_CR44","doi-asserted-by":"publisher","first-page":"E926","DOI":"10.1210\/jc.2014-4204","volume":"100","author":"S Espiard","year":"2015","unstructured":"S. Espiard, L. Drougat, R. Libe, G. Assie, K. Perlemoine, L. Guignat, G. Barrande, F. Brucker-Davis, F. Doullay, S. Lopez, E. Sonnet, F. Torremocha, D. Pinsard, N. Chabbert-Buffet, M.L. Raffin-Sanson, L. Groussin, F. Borson-Chazot, J. Coste, X. Bertagna, C.A. Stratakis, F. Beuschlein, B. Ragazzon, J. Bertherat, ARMC5 mutations in a large cohort of primary macronodular adrenal hyperplasia: clinical and functional consequences. J. Clin. Endocrinol. Metab. 100(6), E926\u2013E935 (2015). https:\/\/doi.org\/10.1210\/jc.2014-4204","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2583_CR45","doi-asserted-by":"publisher","first-page":"E1113","DOI":"10.1210\/jc.2013-4280","volume":"99","author":"FR Faucz","year":"2014","unstructured":"F.R. Faucz, M. Zilbermint, M.B. Lodish, E. Szarek, G. Trivellin, N. Sinaii, A. Berthon, R. Libe, G. Assie, S. Espiard, L. Drougat, B. Ragazzon, J. Bertherat, C.A. Stratakis, Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation. J. Clin. Endocrinol. Metab. 99(6), E1113\u2013E1119 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4280","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2583_CR46","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/a-1107-2972","volume":"52","author":"F Hannah-Shmouni","year":"2020","unstructured":"F. Hannah-Shmouni, C.A. Stratakis, A. Gene-Based, Classification of Primary Adrenocortical Hyperplasias. Horm. Metab. Res. 52(3), 133\u2013141 (2020). https:\/\/doi.org\/10.1055\/a-1107-2972","journal-title":"Horm. Metab. Res."},{"key":"2583_CR47","doi-asserted-by":"publisher","unstructured":"Berthon, A., Bertherat, J.: Update of genetic and molecular causes of adrenocortical hyperplasias causing cushing syndrome. Horm. Metab. Res. (2020). https:\/\/doi.org\/10.1055\/a-1061-7349","DOI":"10.1055\/a-1061-7349"},{"issue":"11","key":"2583_CR48","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","volume":"370","author":"F Beuschlein","year":"2014","unstructured":"F. Beuschlein, M. Fassnacht, G. Assie, D. Calebiro, C.A. Stratakis, A. Osswald, C.L. Ronchi, T. Wieland, S. Sbiera, F.R. Faucz, K. Schaak, A. Schmittfull, T. Schwarzmayr, O. Barreau, D. Vezzosi, M. Rizk-Rabin, U. Zabel, E. Szarek, P. Salpea, A. Forlino, A. Vetro, O. Zuffardi, C. Kisker, S. Diener, T. Meitinger, M.J. Lohse, M. Reincke, J. Bertherat, T.M. Strom, B. Allolio, Constitutive activation of PKA catalytic subunit in adrenal Cushing\u2019s syndrome. N. Engl. J. Med. 370(11), 1019\u20131028 (2014). https:\/\/doi.org\/10.1056\/NEJMoa1310359","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"2583_CR49","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1530\/EJE-14-1154","volume":"172","author":"MB Lodish","year":"2015","unstructured":"M.B. Lodish, B. Yuan, I. Levy, G.D. Braunstein, C. Lyssikatos, P. Salpea, E. Szarek, A.S. Karageorgiadis, E. Belyavskaya, M. Raygada, F.R. Faucz, L. Izzat, C. Brain, J. Gardner, M. Quezado, J.A. Carney, J.R. Lupski, C.A. Stratakis, Germline PRKACA amplification causes variable phenotypes that may depend on the extent of the genomic defect: molecular mechanisms and clinical presentations. Eur. J. Endocrinol. 172(6), 803\u2013811 (2015). https:\/\/doi.org\/10.1530\/EJE-14-1154","journal-title":"Eur. J. Endocrinol"},{"issue":"10","key":"2583_CR50","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1210\/jc.2014-3295","volume":"99","author":"CA Stratakis","year":"2014","unstructured":"C.A. Stratakis, E pluribus unum? The main protein kinase A catalytic subunit (PRKACA), a likely oncogene, and cortisol-producing tumors. J. Clin. Endocrinol. Metab. 99(10), 3629\u20133633 (2014). https:\/\/doi.org\/10.1210\/jc.2014-3295","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"2583_CR51","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1002\/cncr.25724","volume":"117","author":"EE Patterson","year":"2011","unstructured":"E.E. Patterson, A.K. Holloway, J. Weng, T. Fojo, E. Kebebew, MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer 117(8), 1630\u20131639 (2011). https:\/\/doi.org\/10.1002\/cncr.25724","journal-title":"Cancer"},{"issue":"22","key":"2583_CR52","doi-asserted-by":"publisher","first-page":"10753","DOI":"10.1158\/0008-5472.CAN-07-0329","volume":"67","author":"HM Byun","year":"2007","unstructured":"H.M. Byun, H.L. Wong, E.A. Birnstein, E.M. Wolff, G. Liang, A.S. Yang, Examination of IGF2 and H19 loss of imprinting in bladder cancer. Cancer Res. 67(22), 10753\u201310758 (2007). https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-0329","journal-title":"Cancer Res."},{"issue":"11","key":"2583_CR53","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/3260","volume":"4","author":"H Cui","year":"1998","unstructured":"H. Cui, I.L. Horon, R. Ohlsson, S.R. Hamilton, A.P. Feinberg, Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability. Nat. Med. 4(11), 1276\u20131280 (1998). https:\/\/doi.org\/10.1038\/3260","journal-title":"Nat. Med."},{"issue":"8","key":"2583_CR54","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1158\/0008-5472.CAN-09-4456","volume":"70","author":"A Veronese","year":"2010","unstructured":"A. Veronese, L. Lupini, J. Consiglio, R. Visone, M. Ferracin, F. Fornari, N. Zanesi, H. Alder, G. D\u2019Elia, L. Gramantieri, L. Bolondi, G. Lanza, P. Querzoli, A. Angioni, C.M. Croce, M. Negrini, Oncogenic role of miR-483-3p at the IGF2\/483 locus. Cancer Res. 70(8), 3140\u20133149 (2010). https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4456","journal-title":"Cancer Res."},{"issue":"1","key":"2583_CR55","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2009.06.036","volume":"289","author":"I Martin-Kleiner","year":"2010","unstructured":"I. Martin-Kleiner, K. Gall Troselj, Mannose-6-phosphate\/insulin-like growth factor 2 receptor (M6P\/IGF2R) in carcinogenesis. Cancer Lett. 289(1), 11\u201322 (2010). https:\/\/doi.org\/10.1016\/j.canlet.2009.06.036","journal-title":"Cancer Lett"},{"issue":"2","key":"2583_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ghir.2006.12.004","volume":"17","author":"Z Shi","year":"2007","unstructured":"Z. Shi, M.J. Henwood, P. Bannerman, D. Batista, A. Horvath, M. Guttenberg, C.A. Stratakis, A. Grimberg, Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A. Growth Horm. IGF Res. 17(2), 113\u2013121 (2007). https:\/\/doi.org\/10.1016\/j.ghir.2006.12.004","journal-title":"Growth Horm. IGF Res."},{"issue":"19","key":"2583_CR57","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1093\/hmg\/ddl239","volume":"15","author":"M Mavrakis","year":"2006","unstructured":"M. Mavrakis, J. Lippincott-Schwartz, C.A. Stratakis, I. Bossis, Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency. Hum. Mol. Genet. 15(19), 2962\u20132971 (2006). https:\/\/doi.org\/10.1093\/hmg\/ddl239","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"2583_CR58","doi-asserted-by":"publisher","first-page":"E728","DOI":"10.1210\/jc.2010-2420","volume":"96","author":"MQ Almeida","year":"2011","unstructured":"M.Q. Almeida, M. Harran, E.I. Bimpaki, H.P. Hsiao, A. Horvath, C. Cheadle, T. Watkins, M. Nesterova, C.A. Stratakis, Integrated genomic analysis of nodular tissue in macronodular adrenocortical hyperplasia: progression of tumorigenesis in a disorder associated with multiple benign lesions. J. Clin. Endocrinol. Metab. 96(4), E728\u2013E738 (2011). https:\/\/doi.org\/10.1210\/jc.2010-2420","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"2583_CR59","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/ijc.29950","volume":"138","author":"B Altieri","year":"2016","unstructured":"B. Altieri, G. Tirabassi, S. Della Casa, C.L. Ronchi, G. Balercia, F. Orio, A. Pontecorvi, A. Colao, G. Muscogiuri, Adrenocortical tumors and insulin resistance: what is the first step? Int. J. Cancer 138(12), 2785\u20132794 (2016). https:\/\/doi.org\/10.1002\/ijc.29950","journal-title":"Int. J. Cancer"},{"issue":"1","key":"2583_CR60","doi-asserted-by":"publisher","first-page":"43","DOI":"10.23736\/S0391-1977.18.02882-1","volume":"44","author":"B Altieri","year":"2019","unstructured":"B. Altieri, A. Colao, A. Faggiano, The role of insulin-like growth factor system in the adrenocortical tumors. Minerva Endocrinol. 44(1), 43\u201357 (2019). https:\/\/doi.org\/10.23736\/S0391-1977.18.02882-1","journal-title":"Minerva Endocrinol"},{"issue":"1","key":"2583_CR61","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.apsb.2019.05.005","volume":"10","author":"J Zhang","year":"2020","unstructured":"J. Zhang, Z. Yu, G. You, Insulin-like growth factor 1 modulates the phosphorylation, expression, and activity of organic anion transporter 3 through protein kinase A signaling pathway. Acta Pharm. Sin B 10(1), 186\u2013194 (2020). https:\/\/doi.org\/10.1016\/j.apsb.2019.05.005","journal-title":"Acta Pharm. Sin B"},{"issue":"1","key":"2583_CR62","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1677\/jme.0.0230023","volume":"23","author":"A Logie","year":"1999","unstructured":"A. Logie, N. Boulle, V. Gaston, L. Perin, P. Boudou, Y. Le Bouc, C. Gicquel, Autocrine role of IGF-II in proliferation of human adrenocortical carcinoma NCI H295R cell line. J. Mol. Endocrinol. 23(1), 23\u201332 (1999). https:\/\/doi.org\/10.1677\/jme.0.0230023","journal-title":"J. Mol. Endocrinol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02583-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02583-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T12:40:10Z","timestamp":1622119210000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02583-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2583"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02583-z","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,9]]},"assertion":[{"value":"31 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"C.A.S. holds patent on the PRKAR1A, PDE11A, and GPR101 genes and\/or their function and his laboratory has received research funding from Pfizer Inc. F.R.F holds patent on the GPR101 gene and\/or its function. The other authors have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethics approval for the study protocols 1995-CH-0059 and 2000-CH-0160 was obtained from the Institutional Review Board (IRB) in the NIH Office of Intramural Research","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed written consent was obtained from all subjects.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}